Healthcare provider profile · identity verified

Chisom Eze, MD

Internal Medicine · SAINT LOUIS, MO · NPI 1821527649

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Sertraline Hcl	Sertraline Hcl	651	49
Levothyroxine Sodium	Levothyroxine Sodium	606	74
Furosemide	Furosemide	556	63
Amlodipine Besylate	Amlodipine Besylate	544	62
Eliquis	Apixaban	527	61
Atorvastatin Calcium	Atorvastatin Calcium	455	66
Donepezil Hcl	Donepezil Hcl	403	32
Trazodone Hcl	Trazodone Hcl	389	61
Pantoprazole Sodium	Pantoprazole Sodium	382	47
Mirtazapine	Mirtazapine	326	43
Gabapentin	Gabapentin	311	41
Potassium Chloride	Potassium Chloride	306	55
Tamsulosin Hcl	Tamsulosin Hcl	292	34
Escitalopram Oxalate	Escitalopram Oxalate	276	37
Metoprolol Tartrate	Metoprolol Tartrate	267	35
Memantine Hcl	Memantine Hcl	247	25
Quetiapine Fumarate	Quetiapine Fumarate	242	20
Hydralazine Hcl	Hydralazine Hcl	217	21
Lisinopril	Lisinopril	191	30
Losartan Potassium	Losartan Potassium	187	26
Metoprolol Succinate	Metoprolol Succinate	185	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	177	53
Famotidine	Famotidine	172	18
Spironolactone	Spironolactone	133	24
Torsemide	Torsemide	130	20
Allopurinol	Allopurinol	123	16
Duloxetine Hcl	Duloxetine Hcl	121	20
Tramadol Hcl	Tramadol Hcl	103	25
Clopidogrel	Clopidogrel Bisulfate	101	19
Amiodarone Hcl	Amiodarone Hcl	98	11
Carbidopa-Levodopa	Carbidopa/Levodopa	98	14
Ezetimibe	Ezetimibe	96	suppressed
Omeprazole	Omeprazole	96	20
Simvastatin	Simvastatin	93	14
Fenofibrate	Fenofibrate Nanocrystallized	86	suppressed
Risperidone	Risperidone	83	suppressed
Carvedilol	Carvedilol	82	13
Atenolol	Atenolol	81	suppressed
Metformin Hcl	Metformin Hcl	78	14
Bethanechol Chloride	Bethanechol Chloride	76	11
Rosuvastatin Calcium	Rosuvastatin Calcium	74	17
Enalapril Maleate	Enalapril Maleate	66	suppressed
Citalopram Hbr	Citalopram Hydrobromide	65	suppressed
Pravastatin Sodium	Pravastatin Sodium	64	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	15
Xarelto	Rivaroxaban	63	suppressed
Gemtesa	Vibegron	60	suppressed
Loperamide	Loperamide Hcl	58	12
Verapamil Er	Verapamil Hcl	58	suppressed
Primidone	Primidone	57	suppressed
Ondansetron Odt	Ondansetron	56	36
Alprazolam	Alprazolam	55	17
Hydrochlorothiazide	Hydrochlorothiazide	53	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	suppressed
Oxycodone Hcl	Oxycodone Hcl	53	15
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	52	suppressed
Chlorthalidone	Chlorthalidone	52	suppressed
Phenytek	Phenytoin Sodium Extended	52	suppressed
Carbamazepine Er	Carbamazepine	51	suppressed
Finasteride	Finasteride	49	suppressed
Levetiracetam	Levetiracetam	49	12
Latanoprost	Latanoprost	48	15
Divalproex Sodium	Divalproex Sodium	47	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Jardiance	Empagliflozin	44	11
Sucralfate	Sucralfate	44	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	16
Vancomycin Hcl	Vancomycin Hcl	38	suppressed
Glipizide	Glipizide	37	suppressed
Doxepin Hcl	Doxepin Hcl	36	suppressed
Klor-Con M10	Potassium Chloride	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	25
Doxycycline Hyclate	Doxycycline Hyclate	35	17
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	34	14
Insulin Aspart Flexpen	Insulin Aspart	34	suppressed
Nystatin	Nystatin	34	20
Bupropion Xl	Bupropion Hcl	32	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	32	21
Jantoven	Warfarin Sodium	32	suppressed
Levofloxacin	Levofloxacin	32	19
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Lorazepam	Lorazepam	28	17
Folic Acid	Folic Acid	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Baclofen	Baclofen	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Ibuprofen	Ibuprofen	23	14
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Atropine Sulfate	Atropine Sulfate	22	14
Mupirocin	Mupirocin	22	suppressed
Phenobarbital	Phenobarbital	22	suppressed
Ramelteon	Ramelteon	22	suppressed
Sotalol	Sotalol Hcl	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	15
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	21	suppressed
Cefdinir	Cefdinir	21	16
Prednisone	Prednisone	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Colchicine	Colchicine	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	13
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Cephalexin	Cephalexin	19	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Letrozole	Letrozole	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Santyl	Collagenase Clostridium Hist.	18	11
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Moxifloxacin	Moxifloxacin Hcl	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Ozempic	Semaglutide	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nyamyc	Nystatin	15	suppressed
Digoxin	Digoxin	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Benzonatate	Benzonatate	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Motegrity	Prucalopride Succinate	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error